ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Neoplasms, Germ Cell and Embryonal is on this study

  • ClinicalTrials.gov files the study under Neoplasms, Germ Cell and Embryonal.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Neoplasms, Germ Cell and Embryonal.
1 links0 made here, not in the record1 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT01453660Acute Changes inEndothelial Function inGerm Cell Tumor PatientsTreated With Cisplatin andUntreated Germ Cell TumorControlsMemorial Sloan Kettering Canceactive not recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Version of 2026-11-04CONDITIONSNeoplasms, Germ Cell and Em…The registry's MeSH filing›As of now · Rule based · Main conditionMain condition

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 4 · changes seen, not judgments
As of nowNeoplasms, Germ Cell and EmbryonalRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.